Mostrar o registo simplificado do documento

dc.contributor.authorChelemu, W. Cen
dc.contributor.authorDavidson, N. McDen
dc.contributor.authorGlistrup, Len
dc.contributor.authorWalker, Godfrey J. Aen
dc.contributor.authorMoore, G. Den
dc.contributor.authorWorld Health Organization. Action Programme on Essential Drugs and Vaccinesen
dc.contributor.authorDANIDAen
dc.coverage.spatialGeneva
dc.date.accessioned2012-06-16T22:56:15Z
dc.date.available2012-06-16T22:56:15Z
dc.date.created1988en
dc.date.issued1988en
dc.identifier.govdocDAP/88.6. Unpublisheden
dc.identifier.urihttps://iris.who.int/handle/10665/61462
dc.descriptionONLINEen
dc.descriptionDAP/88.6. Unpublisheden
dc.description[‎66]‎ p.en
dc.language.isoenen
dc.publisherWorld Health Organization
dc.publisherWorld Health Organization
dc.subject.meshPharmaceutical Preparationsen
dc.subject.meshNational Health Programsen
dc.subject.meshZimbabween
dc.subject.meshDrugs, Essential
dc.subject.otherPharmacology, Toxicology and Clinical Technologyen
dc.titleZimbabwe national essential drugs program, ZEDAP : joint WHO/DANIDA mid-term review, 19 April - 3 May 1988 / review mission team, W. C. Chelemu ... [‎et al.]‎en
dc.subject.meshqualifiersupply and distributionen


Arquivos para este ítem

Thumbnail

Este documento aparece na(‎s)‎ seguinte(‎s)‎ colecção(‎ões)‎

Mostrar o registo simplificado do documento